MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P, Zhang KS, Tonndorf-Martini E, Weykamp F, Regnery S, Naumann P, Lang K, Ristau J, Körber SA, Dreher C, Buchele C, Rippke C, Renkamp CK, Paul KM, König L, Büsch C, Krisam J, Sedlaczek O, Schlemmer HP, Niyazi M, Corradini S, Debus J, Klüter S, Hörner-Rieber J.
Hoegen P, et al. Among authors: dreher c.
Radiat Oncol. 2022 Mar 27;17(1):59. doi: 10.1186/s13014-022-02033-2.
Radiat Oncol. 2022.
PMID: 35346270
Free PMC article.
Clinical Trial.